Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients.

Neil R Aggarwal,Laurel E Beaty,Tellen D Bennett,Nichole E Carlson,Christopher B Davis,Bethany M Kwan,David A Mayer,Toan C Ong,Seth Russell,Jeffrey Steele,Adane F Wogu,Matthew K Wynia,Richard D Zane,Adit A Ginde

The Journal of infectious diseases（2022）

引用 30|浏览17

暂无评分

摘要

Real-world evidence demonstrated sotrovimab effectiveness in reducing hospitalization and all-cause 28-day mortality among COVID-19 outpatients during the Delta variant phase.

查看译文

关键词

COVID-19,mortality,outpatients,real-world evidence,sotrovimab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要